Skip to main content

Blavatnik Biomedical Accelerator

Forward to Friend Print

FUSION: A unique event for innovative leaders

Harvard’s FUSION symposium integrates perspectives from science and business to explore the promise of an emerging field. This annual, invite-only event brings together entrepreneurs, scientists, business leaders, investors, and innovators for a half-day of exploration and networking. The FUSION symposium is jointly hosted by the Blavatnik Biomedical Accelerator (a program of Harvard University's Office of Technology Development) and by the Blavatnik Fellowship in Life Science Entrepreneurship at Harvard Business School.

The fourth FUSION symposium will address The Science and Business of Cell and Gene Therapy. For more information, contact .(JavaScript must be enabled to view this email address).

FUSION 2019: The Science and Business of Aging


Fusion Recap Thumbnail

FUSION 2019 Recap

While the medical, scientific, and economic challenges related to aging are immense, many scientific and business leaders are engaged and are focused on practical, scalable, innovative solutions. Some solutions already exist, and others aren’t far off. Read the FUSION 2019 Summary

Featured Speakers

  • Sachin H. Jain

    Sachin H. Jain '02, MD'06, MBA '07

    President and Chief Executive Officer, CareMore Health System

    Watch Sachin's video

  • Richard J. Hodes,

    Richard J. Hodes, MD '69

    Director of the National Institute on Aging at the National Institutes of Health

    Watch Richard's video

  • George Church,

    George Church, PhD​ '84

    Robert Winthrop Professor of Genetics, Blavatnik Institute at Harvard Medical School

    Watch George's video

  • Elli Kaplan,

    Elli Kaplan, MBA '05

    Co-founder and Chief Executive Officer, Neurotrack

    Watch Elli's video

  • Nir Barzilai,

    Nir Barzilai, MD

    Professor of Medicine and of Genetics, Albert Einstein College of Medicine; Director of the Institute for Aging Research, Director of the Paul F. Glenn Center for the Biology of Human Aging Research, and Director of the NIH Nathan Shock Centers of Excellence in the Basic Biology of Aging

    Watch Nir's video

  • In many ways, this has proven to be more spectacular than anything that we might have imagined.

    Nitin Nohria

    Dean, Harvard Business School

ADDITIONAL REMARKS:

  • Global population aging is one of the greatest public health challenges of our time. Aging populations will affect the workforce. They will affect families and education and healthcare policies. They will strain healthcare systems, especially those in low-income communities and countries.

    Michelle Williams

    Dean, Harvard T.H. Chan School of Public Health

  • Lending insights to action for the aging world

    The inevitable infirmities of aging may not be so certain after all. Though few products on the market today can help turn back the hands of time, that may soon change.

    Read more in the Harvard Gazette
  • Harvard Gazette logo